Literature DB >> 6966283

Studies on the oligosaccharide chains of human alpha 1-protease inhibitor. II. Structure of oligosaccharides.

T Mega, E Lujan, A Yoshida.   

Abstract

Human alpha 1-protease inhibitor has three oligosaccharide side chains attached to 3 separate asparaginyl residues of the protein by N-glycosyl linkages. Two of the three asparaginyl residues link mostly to the A-type oligosaccharide chains which consist of Man3, Gal2, (GlcNAc)4 and (NeuAc)2. One of the three asparaginyl residues also attaches to a B-type oligosaccharide chain, which consists of Man3, Gal3, (GlcNAc)5, and (NeuAc)3. The ratio of A-chain to B-chain in this particular position is about 2:1. The structures of A- and B-chains of the glycoprotein were examined by periodate oxidation, sequential glycosidase digestion, and permethylation. The results unequivocally revealed the following structure for A-chains. (Formula: see text). B-type oligosaccharide chains have an additional trisaccharide, i.e. NeuAc 2 alpha leads to 3 Gal 1 beta leads to 4 GlcNAc attached to mannose at the (a) and/or (b) position of A-type chains by a beta 1 leads to 4 linkage. The sialic acid of human alpha 1-protease inhibitor was determined to be N-acetylneuraminic acid.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6966283

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Studies on the interaction between hyaluronan and a rat colon cancer cell line.

Authors:  C Samuelsson; S Gustafson
Journal:  Glycoconj J       Date:  1998-02       Impact factor: 2.916

2.  Sulphation of proteins secreted by a human hepatoma-derived cell line. Sulphation of N-linked oligosaccharides on alpha 2HS-glycoprotein.

Authors:  G Hortin; E D Green; J U Baenziger; A W Strauss
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

3.  Cloning and sequence of cDNA coding for alpha 1-antitrypsin.

Authors:  K Kurachi; T Chandra; S J Degen; T T White; T L Marchioro; S L Woo; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

4.  Production of glycosylated physiologically "normal" human alpha 1-antitrypsin by mouse fibroblasts modified by insertion of a human alpha 1-antitrypsin cDNA using a retroviral vector.

Authors:  R I Garver; A Chytil; S Karlsson; G A Fells; M L Brantly; M Courtney; P W Kantoff; A W Nienhuis; W F Anderson; R G Crystal
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

5.  Castanospermine inhibits glucosidase I and glycoprotein secretion in human hepatoma cells.

Authors:  V W Sasak; J M Ordovas; A D Elbein; R W Berninger
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

6.  Comparative rates of transfer of N-acetylneuraminic acid to acceptors bearing one or more Gal(beta 1-4)GlcNAc terminus by the Gal(beta 1-4)GlcNAc(NeuAc-Gal) (alpha 2-6)-sialyltransferase from embryonic chicken liver. Utilization of oligosaccharides as acceptors in sialyltransferase assays.

Authors:  B Bendiak; G M Cook
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

7.  Alpha 1-antitrypsin: apparent molecular weight heterogeneity shown by two-dimensional electrophoresis.

Authors:  W T Brown
Journal:  Am J Hum Genet       Date:  1982-03       Impact factor: 11.025

8.  Severe rheumatoid arthritis prohibits the pregnancy-induced decrease in alpha3-fucosylation of alpha1-acid glycoprotein.

Authors:  E C Havenaar; J S Axford; E C Brinkman-van der Linden; A Alavi; E C Van Ommen; B van het Hof; T Spector; A Mackiewicz; W Van Dijk
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

9.  Enzymatic characterization of CMP-NeuAc:Gal beta 1-4GlcNAc-R alpha(2-3)-sialyltransferase from human placenta.

Authors:  M Nemansky; D H van den Eijnden
Journal:  Glycoconj J       Date:  1993-02       Impact factor: 2.916

10.  Glycoproteomic Analysis of Malignant Ovarian Cancer Ascites Fluid Identifies Unusual Glycopeptides.

Authors:  Suzanne Miyamoto; L Renee Ruhaak; Carol Stroble; Michelle R Salemi; Brett Phinney; Carlito B Lebrilla; Gary S Leiserowitz
Journal:  J Proteome Res       Date:  2016-08-23       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.